about
Clinically Available Medicines Demonstrating Anti-Toxoplasma ActivityAnti-Toxoplasma gondii activities and structure-activity relationships of novel fluoroquinolones related to trovafloxacinQuinupristin-dalfopristin is active against Toxoplasma gondiiAnti-toxoplasma activities of 24 quinolones and fluoroquinolones in vitro: prediction of activity by molecular topology and virtual computational techniquesActivity of gatifloxacin alone or in combination with pyrimethamine or gamma interferon against Toxoplasma gondiiTwo 2-hydroxy-3-alkyl-1,4-naphthoquinones with in vitro and in vivo activities against Toxoplasma gondii.Activity of trovafloxacin in combination with other drugs for treatment of acute murine toxoplasmosisEffects of 2',3'-dideoxyinosine on Toxoplasma gondii cysts in miceCiprofloxacin Derivatives Affect Parasite Cell Division and Increase the Survival of Mice Infected with Toxoplasma gondiiEffect of trovafloxacin on production of cytokines by human monocytes.Pharmacokinetics of [18F]trovafloxacin in healthy human subjects studied with positron emission tomography.Unique features of apicoplast DNA gyrases from Toxoplasma gondii and Plasmodium falciparum.The manzamines as an example of the unique structural classes available for the discovery and optimization of infectious disease controls based on marine natural products.Drugs in development for toxoplasmosis: advances, challenges, and current status.Enrofloxacin and Toltrazuril Are Able to Reduce Toxoplasma gondii Growth in Human BeWo Trophoblastic Cells and Villous Explants from Human Third Trimester Pregnancy.DNA topoisomerases in apicomplexan parasites: promising targets for drug discovery
P2860
Q26782581-971324CD-D5B5-4288-AA1D-52B92CDA0593Q28343422-5A24D07F-1614-42DD-98DE-DE51E89847C7Q28343473-6F372CD0-16F1-472C-BC87-D72D38426262Q28344751-B6193BA7-3707-4BBF-B953-AB903B87E550Q28345231-87F4372A-B0DE-40E3-8D9C-536E51CF3B45Q28368883-6AFE690A-4D00-4F53-8EA3-46BBCE3D44B5Q28378877-ADE82100-7DB4-4784-A216-196B038AF98AQ28379020-3FD89436-3F4C-4F3A-B85A-017689D96D6DQ28547065-5A1CEAE9-76F1-4221-9542-CA3A40D0C273Q33694154-2F2AD64E-07EE-4E84-B965-27DC73ED39E2Q33695030-2976EE1F-1CD8-4B5D-825E-38FCB393D6E6Q35530176-CED249F3-0DB1-46CB-8687-0D82AFAD1B2FQ36754650-9280850B-DB66-4C8E-80C7-D7E734A445E6Q37613765-007278C5-1285-4399-B680-8A9355792623Q40097660-BF77047D-0D3A-4D3D-AE6E-8A50A4E99F45Q56432854-9096FF96-D02C-4CCB-AF91-EFF9EA12E83C
P2860
description
1996 nî lūn-bûn
@nan
1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Trovafloxacin is active against Toxoplasma gondii
@ast
Trovafloxacin is active against Toxoplasma gondii
@en
Trovafloxacin is active against Toxoplasma gondii
@nl
type
label
Trovafloxacin is active against Toxoplasma gondii
@ast
Trovafloxacin is active against Toxoplasma gondii
@en
Trovafloxacin is active against Toxoplasma gondii
@nl
prefLabel
Trovafloxacin is active against Toxoplasma gondii
@ast
Trovafloxacin is active against Toxoplasma gondii
@en
Trovafloxacin is active against Toxoplasma gondii
@nl
P2093
P2860
P1476
Trovafloxacin is active against Toxoplasma gondii
@en
P2093
F G Araujo
J S Remington
P2860
P304
P407
P577
1996-08-01T00:00:00Z